Seeing Is Believing
Currently out of the existing stock ratings of Yasmeen Rahimi, 262 are a BUY (94.58%), 15 are a HOLD (5.42%).
Analyst Yasmeen Rahimi, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 30.91% that have a potential upside of 39.52% achieved within 185 days.
Yasmeen Rahimi’s has documented 537 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Industrials, Technology sectors.
Most recent stock forecast was given on EWTX, Edgewise Therapeutics at 02-Apr-2025.
Analyst best performing recommendations are on PRAX (PRAXIS PRECISION MEDICINES ).
The best stock recommendation documented was for MDGL (MADRIGAL PHARMACEUTICALS) at 11/30/2017. The price target of $82 was fulfilled within 6 days with a profit of $31.66 (62.89%) receiving and performance score of 104.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$42
$-2.15 (-4.87%)
$42
2 years 1 months 20 days ago
(15-Feb-2023)
0/15 (0%)
$-2.18 (-4.93%)
Buy
$42
$-2.15 (-4.87%)
$82
2 years 2 months 24 days ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Buy
$42
$-2.15 (-4.87%)
$68
2 years 2 months 24 days ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold
$55
2 years 2 months 24 days ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Hold
$42
$-2.15 (-4.87%)
$61
2 years 2 months 26 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
Which stock is Yasmeen Rahimi is most bullish on?
Which stock is Yasmeen Rahimi is most reserved on?
What Year was the first public recommendation made by Yasmeen Rahimi?